Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COMMON-STOCK
-
Shares outstanding
-
7.23M
-
Number of holders
-
103
-
Total 13F shares, excl. options
-
39.4M
-
Shares change
-
+11.6M
-
Total reported value, excl. options
-
$658M
-
Value change
-
+$203M
-
Put/Call ratio
-
0.29
-
Number of buys
-
68
-
Number of sells
-
-29
-
Price
-
$16.72
Significant Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR) as of Q4 2021
118 filings reported holding KZR - Kezar Life Sciences Inc - COMMON-STOCK as of Q4 2021.
Kezar Life Sciences Inc - COMMON-STOCK (KZR) has 103 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39.4M shares
.
Largest 10 shareholders include Bellevue Group AG (4.92M shares), Avidity Partners Management LP (3.23M shares), BlackRock Inc. (2.69M shares), FRANKLIN RESOURCES INC (2.49M shares), Point72 Asset Management, L.P. (2.11M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (2.06M shares), VANGUARD GROUP INC (1.89M shares), Logos Global Management LP (1.45M shares), MORGAN STANLEY (1.44M shares), and SUVRETTA CAPITAL MANAGEMENT, LLC (1.41M shares).
This table shows the top 103 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.